Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | SRC | P12931 | 1/20 | 0.45 |
| ▸ | PPARG | P37231 | 4/20 | 0.44 |
| ▸ | PPARA | Q07869 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ACP3 | P15309 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17724521 | 1.00 | CYP2D6 (0.45) | CYP2D6SRCPPARGPPARALMNA | |
| Hydrochloric Acid SCHEMBL2530813 | 0.98 | CYP2D6 (0.43) | CYP2D6SRCPPARGPPARALMNA | |
| SCHEMBL6963705 | 0.86 | ALDH1A1 (0.40) | CYP2D6SRCPPARGPPARALMNA | |
| SCHEMBL3458611 | 0.85 | EPHX1 (0.43) | CYP2D6SRCALDH1A1CYP3A4 | |
| SCHEMBL27715833 | 0.85 | PPARG (0.39) | CYP2D6SRCPPARGPPARALMNA | |
| SCHEMBL4980942 | 0.83 | PPARG (0.41) | CYP2D6SRCPPARGPPARALMNA | |
| SCHEMBL29280042 | 0.83 | LDHA (0.42) | PPARGPPARAALDH1A1 | |
| SCHEMBL4658943 | 0.80 | POLB (0.56) | LMNAALDH1A1POLB | |
| SCHEMBL7797901 | 0.80 | CYP2C19 (0.38) | CYP2D6SRCLMNAMAPK1ALDH1A1 | |
| SCHEMBL8080541 | 0.80 | CYP2D6 (0.45) | CYP2D6SRCPPARGPPARALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346778-A1 | FLUORINE-CONTAINING COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2025-11-13 | — | — | US | disclosed |
| US-20250340752-A1 | FLUORINATED POLYMER | DAIKIN INDUSTRIES, LTD. (JP) | 2025-11-06 | — | — | US | disclosed |
| US-20250333902-A1 | FLUORINE-CONTAINING COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2025-10-30 | — | — | US | disclosed |
| EP-4574872-A1 | FLUORINE-CONTAINING COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2025-06-25 | — | — | EP | disclosed |
| EP-4538304-A1 | FLUORINATED POLYMER | DAIKIN INDUSTRIES, LTD. (JP) | 2025-04-16 | — | — | EP | disclosed |
| EP-4516773-A1 | FLUORINE-CONTAINING COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2025-03-05 | — | — | EP | disclosed |
| WO-2024185687-A1 | FLUORINE-CONTAINING COMPOUND | ダイキン工業株式会社 | 2024-09-12 | — | — | WO | disclosed |
| WO-2024185707-A1 | FLUORINE-CONTAINING COMPOUND | ダイキン工業株式会社 | 2024-09-12 | — | — | WO | disclosed |
| WO-2024185688-A1 | FLUORINATED POLYMER | ダイキン工業株式会社 | 2024-09-12 | — | — | WO | disclosed |
| CN-118239953-A | Compounds for the treatment of PI3K gamma mediated diseases and uses thereof | 中国科学院合肥物质科学研究院 | 2024-06-25 | — | — | CN | disclosed |
| US-20090029999-A1 | Synephrine derivatives useful as anti-inflammatory agents | UNIVERSITEIT GENT (BE) | 2009-01-29 | — | — | US | disclosed |
| EP-1957473-A2 | PROCESS FOR PREPARING SUBSTITUTED ARYL CYCLOALKANOL DERIVATIVES | Wyeth a Corporation of the State of Delaware (US) | 2008-08-20 | — | — | EP | disclosed |
| WO-2007067575-A2 | PROCESS FOR PREPARING SUBSTITUTED ARYL CYCLOALKANOL DERIVATIVES | WYETH (US) | 2007-06-14 | — | — | WO | disclosed |
| US-20070129377-A1 | Process for Preparing Substituted Aryl Cycloalkanol Derivatives | WYETH (US) | 2007-06-07 | — | — | US | disclosed |
| US-20050026929-A1 | Novel phenyl derivatives as inducers of apoptosis | AXYS PHARMACEUTICALS, INC. (US) | 2005-02-03 | — | — | US | disclosed |
| CN-1575191-A | Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors | PFIZER PROD INC (US) | 2005-02-02 | — | — | CN | disclosed |
| WO-2003090680-A2 | NOVEL PHENYL DERIVATIVES AS INDUCERS OF APOPTOSIS | AXYS PHARMACEUTICALS, INC. (US) | 2003-11-06 | — | — | WO | disclosed |
| CN-1093124-C | Substituted 4-hydroxy-phenylalcanoic acid derivatives with activity to ppar-'gamma' | GLAXO GROUP LTD (GB) | 2002-10-23 | — | — | CN | disclosed |
| CN-1218460-A | Substituted 4-hydroxy-phenylalcanoic acid derivatives with activity to ppar-'gamma' | GLAXO GROUP LTD (GB) | 1999-06-02 | — | — | CN | disclosed |
| EP-0608894-A1 | Positive-type photosensitive resin compositions | Nippon Paint Co., Ltd. (JP) | 1994-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090029999-A1 | Synephrine derivatives useful as anti-inflammatory agents | HRH1, HRH3, HRH2 | CYP2D6 3868/4885SRC 2667/4885PPARG 1096/4885 |
| US-20070129377-A1 | Process for Preparing Substituted Aryl Cycloalkanol Derivatives | CYP1A2, CYP3A7, CYP3A43 | CYP2D6 20/4885SRC 896/4885PPARG 499/4885 |
| US-20050026929-A1 | Novel phenyl derivatives as inducers of apoptosis | BAX, BAD, CASP3 | CYP2D6 1534/4885SRC 773/4885PPARG 136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.